168 related articles for article (PubMed ID: 16885049)
1. Molecular and clinical correlates in iron overload associated with mutations in ferroportin.
De Domenico I; McVey Ward D; Nemeth E; Ganz T; Corradini E; Ferrara F; Musci G; Pietrangelo A; Kaplan J
Haematologica; 2006 Aug; 91(8):1092-5. PubMed ID: 16885049
[TBL] [Abstract][Full Text] [Related]
2. G80S-linked ferroportin disease: classical ferroportin disease in an Asian family and reclassification of the mutant as iron transport defective.
McDonald CJ; Wallace DF; Ostini L; Bell SJ; Demediuk B; Subramaniam VN
J Hepatol; 2011 Mar; 54(3):538-44. PubMed ID: 21094556
[TBL] [Abstract][Full Text] [Related]
3. Iron overload due to mutations in ferroportin.
De Domenico I; Ward DM; Musci G; Kaplan J
Haematologica; 2006 Jan; 91(1):92-5. PubMed ID: 16434376
[TBL] [Abstract][Full Text] [Related]
4. Ferroportin diseases: functional studies, a link between genetic and clinical phenotype.
Détivaud L; Island ML; Jouanolle AM; Ropert M; Bardou-Jacquet E; Le Lan C; Mosser A; Leroyer P; Deugnier Y; David V; Brissot P; Loréal O
Hum Mutat; 2013 Nov; 34(11):1529-36. PubMed ID: 23943237
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis and theoretical modeling of ferroportin reveals clustering of mutations according to phenotype.
Wallace DF; Harris JM; Subramaniam VN
Am J Physiol Cell Physiol; 2010 Jan; 298(1):C75-84. PubMed ID: 19846751
[TBL] [Abstract][Full Text] [Related]
6. Ferroportin disease: pathogenesis, diagnosis and treatment.
Pietrangelo A
Haematologica; 2017 Dec; 102(12):1972-1984. PubMed ID: 29101207
[TBL] [Abstract][Full Text] [Related]
7. In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations.
Schimanski LM; Drakesmith H; Merryweather-Clarke AT; Viprakasit V; Edwards JP; Sweetland E; Bastin JM; Cowley D; Chinthammitr Y; Robson KJ; Townsend AR
Blood; 2005 May; 105(10):4096-102. PubMed ID: 15692071
[TBL] [Abstract][Full Text] [Related]
8. Lack of enterocyte iron accumulation in the ferroportin disease.
Corradini E; Montosi G; Ferrara F; Caleffi A; Pignatti E; Barelli S; Garuti C; Pietrangelo A
Blood Cells Mol Dis; 2005; 35(3):315-8. PubMed ID: 16135412
[TBL] [Abstract][Full Text] [Related]
9. The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease.
Zohn IE; De Domenico I; Pollock A; Ward DM; Goodman JF; Liang X; Sanchez AJ; Niswander L; Kaplan J
Blood; 2007 May; 109(10):4174-80. PubMed ID: 17289807
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease.
Pietrangelo A; Corradini E; Ferrara F; Vegetti A; De Jong G; Luca Abbati G; Paolo Arcuri P; Martinelli S; Cerofolini E
Blood Cells Mol Dis; 2006; 37(3):192-6. PubMed ID: 17052926
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation in ferroportin implicated in iron overload.
Wallace DF; Dixon JL; Ramm GA; Anderson GJ; Powell LW; Subramaniam VN
J Hepatol; 2007 May; 46(5):921-6. PubMed ID: 17383046
[TBL] [Abstract][Full Text] [Related]
12. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin.
Drakesmith H; Schimanski LM; Ormerod E; Merryweather-Clarke AT; Viprakasit V; Edwards JP; Sweetland E; Bastin JM; Cowley D; Chinthammitr Y; Robson KJ; Townsend AR
Blood; 2005 Aug; 106(3):1092-7. PubMed ID: 15831700
[TBL] [Abstract][Full Text] [Related]
13. Zebrafish as a model for defining the functional impact of mammalian ferroportin mutations.
De Domenico I; Vaughn MB; Yoon D; Kushner JP; Ward DM; Kaplan J
Blood; 2007 Nov; 110(10):3780-3. PubMed ID: 17726163
[TBL] [Abstract][Full Text] [Related]
14. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload.
Mayr R; Griffiths WJ; Hermann M; McFarlane I; Halsall DJ; Finkenstedt A; Douds A; Davies SE; Janecke AR; Vogel W; Cox TM; Zoller H
Gastroenterology; 2011 Jun; 140(7):2056-63, 2063.e1. PubMed ID: 21396368
[TBL] [Abstract][Full Text] [Related]
15. Evidence for dimerization of ferroportin in a human hepatic cell line using proximity ligation assays.
Rishi G; Secondes ES; Wallace DF; Subramaniam VN
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32301493
[TBL] [Abstract][Full Text] [Related]
16. Effect of ferroportin polymorphism on iron homeostasis and infection.
Kasvosve I
Clin Chim Acta; 2013 Feb; 416():20-5. PubMed ID: 23178444
[TBL] [Abstract][Full Text] [Related]
17. The molecular basis of ferroportin-linked hemochromatosis.
De Domenico I; Ward DM; Nemeth E; Vaughn MB; Musci G; Ganz T; Kaplan J
Proc Natl Acad Sci U S A; 2005 Jun; 102(25):8955-60. PubMed ID: 15956209
[TBL] [Abstract][Full Text] [Related]
18. Ferroportin deficiency in erythroid cells causes serum iron deficiency and promotes hemolysis due to oxidative stress.
Zhang DL; Ghosh MC; Ollivierre H; Li Y; Rouault TA
Blood; 2018 Nov; 132(19):2078-2087. PubMed ID: 30213870
[TBL] [Abstract][Full Text] [Related]
19. Human mutation D157G in ferroportin leads to hepcidin-independent binding of Jak2 and ferroportin down-regulation.
De Domenico I; Lo E; Ward DM; Kaplan J
Blood; 2010 Apr; 115(14):2956-9. PubMed ID: 20124516
[TBL] [Abstract][Full Text] [Related]
20. A novel missense mutation in SLC40A1 results in resistance to hepcidin and confirms the existence of two ferroportin-associated iron overload diseases.
Létocart E; Le Gac G; Majore S; Ka C; Radio FC; Gourlaouen I; De Bernardo C; Férec C; Grammatico P
Br J Haematol; 2009 Nov; 147(3):379-85. PubMed ID: 19709084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
